Brief: Pliant Therapeutics Q4 Net Income USD -49.732 Million
03/03/2025 21:05
Mar 03 (Reuters) - Pliant Therapeutics Q4 operating expenses USD -53.32 million. Q4 operating income USD -53.32 million
Recent news on Pliant Therapeutics
See all newsBrief: Pliant Therapeutics Announces Presentations At The 2026 Annual Meeting
Brief: Pliant Therapeutics Appoints David Raben, M.D., As Chief Medical Officer
RCS - Redx Pharma Limited - Redx Announces Final Audited Results
RCS - Redx Pharma Limited - Close of Series A; Strengthened Board Composition
U.S. STOCKS ON THE MOVE-Gold miners, Weave Communications, Amylyx Pharmaceuticals